Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the effect of infliximab to the children who
don't respond to the first dose of intravenous immunoglobulin (IVIG) (2g/kg) in Kawasaki
disease.
Phase:
Phase 3
Details
Lead Sponsor:
Fudan University
Collaborators:
Shanghai 10th People's Hospital Shanghai 8th People's Hospital Shanghai Children's Medical Center Shanghai Xuhui Distrct Center Hospital